DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1470-7330
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center ; volume:17 ; number:1 ; day:6 ; month:2 ; year:2017 ; pages:1-9 ; date:12.2017
Cancer imaging ; 17, Heft 1 (6.2.2017), 1-9, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Luz, Jose Hugo Mendes
- Beteiligte Personen und Organisationen
-
Luz, Paula M.
Martin, Henrique S.
Gouveia, Hugo R.
Levigard, Raphal Braz
Nogueira, Felipe Diniz
Rodrigues, Bernardo Caetano
de Miranda, Tiago Nepomuceno
Mamede, Marcelo Henrique
SpringerLink (Online service)
- DOI
-
10.1186/s40644-017-0108-6
- URN
-
urn:nbn:de:1111-201703028910
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Luz, Jose Hugo Mendes
- Luz, Paula M.
- Martin, Henrique S.
- Gouveia, Hugo R.
- Levigard, Raphal Braz
- Nogueira, Felipe Diniz
- Rodrigues, Bernardo Caetano
- de Miranda, Tiago Nepomuceno
- Mamede, Marcelo Henrique
- SpringerLink (Online service)
Ähnliche Objekte (12)
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Complications after TACE in HCC – Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
CXCL1 and CXCL6 are potential predictors for HCC response to TACE
Machine learning zur Verbesserung der Vorhersagequalität nach TACE bei HCC-Patienten
Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Complications after TACE in HCC – Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
CXCL1 and CXCL6 are potential predictors for HCC response to TACE
Machine learning zur Verbesserung der Vorhersagequalität nach TACE bei HCC-Patienten
Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?
A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Complications after TACE in HCC – Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom
Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose
Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
CXCL1 and CXCL6 are potential predictors for HCC response to TACE
Machine learning zur Verbesserung der Vorhersagequalität nach TACE bei HCC-Patienten
Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?